Amneal Pharmaceuticals, Inc.
AMRX
$11.92
-$0.20-1.61%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 286.47M | 203.48M | 75.28M | 61.63M | 112.42M |
| Total Receivables | 939.87M | 924.14M | 849.27M | 800.29M | 808.56M |
| Inventory | 606.30M | 614.50M | 608.97M | 601.43M | 612.45M |
| Prepaid Expenses | 49.70M | 61.64M | 41.53M | 40.52M | 46.50M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 28.84M | 34.73M | 9.64M | 6.58M | 7.87M |
| Total Current Assets | 1.91B | 1.84B | 1.58B | 1.51B | 1.59B |
|
|
|||||
| Total Current Assets | 1.91B | 1.84B | 1.58B | 1.51B | 1.59B |
| Net Property, Plant & Equipment | 550.33M | 538.06M | 546.29M | 522.75M | 523.69M |
| Long-term Investments | 595.47M | 595.95M | 597.41M | 597.50M | 597.44M |
| Goodwill | 595.47M | 595.95M | 597.41M | 597.50M | 597.44M |
| Total Other Intangibles | 563.50M | 587.94M | 649.55M | 689.14M | 732.38M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 52.05M | 34.29M | 28.41M | 21.65M | 24.21M |
| Total Assets | 3.68B | 3.60B | 3.42B | 3.37B | 3.50B |
|
|
|||||
| Total Accounts Payable | 254.93M | 266.70M | 206.98M | 194.07M | 259.84M |
| Total Accrued Expenses | 328.59M | 289.50M | 292.68M | 262.20M | 317.53M |
| Short-term Debt | -- | -- | 290.00M | 290.00M | 100.00M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 21.58M | 21.47M | 45.41M | 47.54M | 240.26M |
| Total Finance Division Other Current Liabilities | 276.54M | 284.44M | 272.07M | 282.02M | 212.14M |
| Total Other Current Liabilities | 276.54M | 284.44M | 272.07M | 282.02M | 212.14M |
| Total Current Liabilities | 881.63M | 862.11M | 1.11B | 1.08B | 1.13B |
|
|
|||||
| Total Current Liabilities | 881.63M | 862.11M | 1.11B | 1.08B | 1.13B |
| Long-Term Debt | 2.57B | 2.57B | 2.15B | 2.15B | 2.16B |
| Short-term Debt | -- | -- | 290.00M | 290.00M | 100.00M |
| Capital Leases | 102.36M | 97.75M | 100.08M | 87.98M | 91.09M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 123.21M | 115.69M | 115.90M | 106.86M | 163.33M |
| Total Liabilities | 3.67B | 3.64B | 3.47B | 3.42B | 3.55B |
|
|
|||||
| Common Stock & APIC | 574.94M | 566.51M | 557.76M | 548.94M | 563.31M |
| Retained Earnings | -535.01M | -570.08M | -572.45M | -594.87M | -607.06M |
| Treasury Stock & Other | -110.73M | -105.88M | -97.43M | -85.74M | -65.51M |
| Total Common Equity | -70.79M | -109.46M | -112.12M | -131.67M | -109.27M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -70.79M | -109.46M | -112.12M | -131.67M | -109.27M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 76.76M | 67.28M | 65.39M | 72.28M | 64.73M |
| Total Equity | 5.96M | -42.18M | -46.73M | -59.39M | -44.54M |
|
|
|||||